Quadrilaterals containing one or more other geometrical figures -- Note: Including quadrilaterals containing bent or straight lines (except 26.4.11).Quadrilatères contenant une ou plusieurs autres figures géométriques -- Note: Y compris les quadrilatères contenant des lignes courbées ou droites (excepté 26.4.11).

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

26 . 3 . 23

Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.

26 . 4 . 26

Quadrilaterals with cutout areasQuadrilatères avec des zones découpées

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 8

Horizontal lines or bandsLignes ou bandes horizontales

26 . 11 . 11

Broken lines or bands (except a 26.11.13)Lignes ou bandes brisées (excepté a 26.11.13)

1 . 13 . 1

Armillary spheres, planetaria, astronomic orbits, atomic models, molecular modelsSphères armillaires, planétariums, orbites astronomiques, schémas d'atomes, schémas de molécules

1 . 13 . 15

Atomic models, molecular models, representations of human, animal or vegetal cells, images of bacteria or viruses, DNA helixesSchémas atomiques, schémas de molécules, représentations de cellules humaines, animales ou végétales, images de bactéries ou de virus, hélices d'ADN

Trademark usage description

gene therapy products, namely biopharmaceutical preparations, primarily comprised of adeno-associated virus (aav) vectors comprising a transgene for d Read More

Classification Information

Class [005]
Gene therapy products, namely biopharmaceutical preparations, primarily comprised of adeno-associated virus (AAV) vectors comprising a transgene for delivery to a cell or tissue, for the treatment of rare genetic diseases, conditions and disorders of muscle and the central nervous system, namely, diseases, disorders, infections, and conditions of the central nervous system, namely brain, movement, and ocular motility diseases, neurodegenerative diseases, spinal cord diseases, brain diseases, muscle degeneration, muscle weakness and paralysis; biological preparations for medical, therapeutic and clinical gene therapy, namely, biopharmaceutical preparations, primarily comprised of adeno-associated virus (AAV) vectors comprising a transgene for delivery to a cell or tissue for the treatment of rare genetic diseases, conditions and disorders of muscle and the central nervous system, namely, diseases, disorders, infections, and conditions of the central nervous system, namely brain, movement, and ocular motility diseases, neurodegenerative diseases, spinal cord diseases, brain diseases, muscle degeneration, muscle weakness and paralysis.

Classification kind code

Mark Details

Serial Number

2074540

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 13^th Apr 2022	Search Recorded
Submitted for opposition 20 on 13^th Apr 2022	Examiner's First Report
Submitted for opposition 223 on 13^th Apr 2022	Total Provisional Refusal
Submitted for opposition 256 on 01^st Nov 2021	Notification of Possible Opposition Sent
Submitted for opposition 48 on 16^th Feb 2021	Agent Changed
Submitted for opposition 257 on 31^st Dec 2020	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 30^th Dec 2020	Created
Submitted for opposition 31 on 30^th Dec 2020	Formalized
Submitted for opposition 30 on 12^th Nov 2020	Filed
Submitted for opposition 228 on 12^th Nov 2020	International Registration